Skip to main content

Table 4 Serum hormone concentrations of non-pregnant dialysis patients and of subgroups according to menstrual cycle status and menopausal status

From: Exclusion of pregnancy in dialysis patients: diagnostic performance of human chorionic gonadotropin

Hormone

  

Serum concentration

   
 

Non-pregnant

Menstrual cycle (n = 67)a

Menopause (n = 69)

  

Regular

Irregular

Amenorrhea

No or functional

Pre- or true

(manufacturer and method)

(n = 69)

(n = 29)

(n = 13)

(n = 25)

(n = 46)

(n = 23)

hCG (Roche, ECLIA), mlU/ml

1.0 (< 0.1–2.0)

1.0 (0.1–1.0).

0.1 (0.1–1.0)

1.0 (0.5–6.0)

0.1 (0.1–1.0)

4.0 (1.5–7.45)

LH (Roche, ECLIA), mlU/ml

9.45 (3.9–33.2)

10.15 (3.98–27.6)b

7.7 (4.2–11.6)

10.4 (3.6–95.5)

7.1 (3.6–15.7)b

82.3 (4.4–120.8)

FSH (Roche, ECLIA), mlU/ml

5.40 (3.90–22.7)

5.0 (3.55–9.75)b

4.4 (3.9–6.0)

21.7 (4.2–80.0)

4.6 (3.6–6.3)b

58.3 (18.5–117)

AMH (Beckman-Coulter, ELISA; n = 33), ng/ml

0.16 (< 0.08–3.2)

0.66 (0.1–3.44)

4.2 (0.86–6.3)

0.08 (< 0.08–0.33)

0.73 (0.31–5.46)

0.08 (< 0.08- < 0.08)

 n

33

14

6

12

21

12

AMH (Roche, ECLIA; n = 35), ng/ml

0.19 (0.01–0.8)b

0.36-(0.15–1.62)b

0.37 (0.2–0.96)

0.01 (0.01–0.04)

0.38 (0.18–1.71)b

0.01 (0.01–0.03)

 n

35b

14b

7

13

24b

11

  1. hCG human chorionic gonadotropin, LH luteinizing hormone, FSH follicle stimulating hormone, AMH anti-Müllerian hormone, ECLIA electrochemiluminescence immunoassay, ELISA enzyme linked immunosorbent assay
  2. Data expressed as median (IQR); a unknown menstrual cycle status in two patients; b 1 missing